These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26857460)

  • 1. Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.
    Marziali G; Signore M; Buccarelli M; Grande S; Palma A; Biffoni M; Rosi A; D'Alessandris QG; Martini M; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Sci Rep; 2016 Feb; 6():21557. PubMed ID: 26857460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
    Rosi A; Ricci-Vitiani L; Biffoni M; Grande S; Luciani AM; Palma A; Runci D; Cappellari M; De Maria R; Guidoni L; Pallini R; Viti V
    NMR Biomed; 2015 Mar; 28(3):317-26. PubMed ID: 25581615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
    Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
    Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.
    Sana J; Busek P; Fadrus P; Besse A; Radova L; Vecera M; Reguli S; Stollinova Sromova L; Hilser M; Lipina R; Lakomy R; Kren L; Smrcka M; Sedo A; Slaby O
    Sci Rep; 2018 Feb; 8(1):2836. PubMed ID: 29434344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
    Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature.
    Steponaitis G; Tamasauskas A
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H NMR detects different metabolic profiles in glioblastoma stem-like cells.
    Guidoni L; Ricci-Vitiani L; Rosi A; Palma A; Grande S; Luciani AM; Pelacchi F; di Martino S; Colosimo C; Biffoni M; De Maria R; Pallini R; Viti V
    NMR Biomed; 2014 Feb; 27(2):129-45. PubMed ID: 24142746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.
    Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
    Mol Oncol; 2023 Feb; 17(2):238-260. PubMed ID: 36495079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.
    Galavotti S; Bartesaghi S; Faccenda D; Shaked-Rabi M; Sanzone S; McEvoy A; Dinsdale D; Condorelli F; Brandner S; Campanella M; Grose R; Jones C; Salomoni P
    Oncogene; 2013 Feb; 32(6):699-712. PubMed ID: 22525272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme.
    Liang J; Meng Q; Zhao W; Tong P; Li P; Zhao Y; Zhao X; Li H
    Sci Rep; 2016 Oct; 6():34556. PubMed ID: 27698411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
    Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
    Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome.
    Miconi G; Palumbo P; Dehcordi SR; La Torre C; Lombardi F; Evtoski Z; Cimini AM; Galzio R; Cifone MG; Cinque B
    J Cell Biochem; 2015 May; 116(5):864-76. PubMed ID: 25559650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of prognosis prediction models based on pathway‑level, gene‑level and clinical information for glioblastoma.
    Liang R; Wang M; Zheng G; Zhu H; Zhi Y; Sun Z
    Int J Mol Med; 2018 Oct; 42(4):1837-1846. PubMed ID: 30015853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
    Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
    Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.